Search Results 211-220 of 18178 for peptides

  1. An Evaluation of the MitraClip System for treatment of Mitral Regurgitation in Heart Failure Patients - Mayo Clinic

    ... peptide (BNP) ≥300 pg/ml or corrected n-Terminal pro- brain natriuretic peptide NT-proBNP ≥1500 pg/ml measured within 90 days prior to subject ...

  2. A Study to Evaluate Bardoxolone Methyl in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) - Mayo Clinic

    - B-type natriuretic peptide (BNP) level > 200 pg/mL at Screen A visit; - Uncontrolled diabetes (HbA1c > 11.0%) at Screen A visit; - Serum albumin < 3 g/dL ...

  3. Adrian Vella, M.D. - Mayo Clinic Faculty Profiles

    Glucagon-like peptide 1 (GLP-1) is an incretin hormone that powerfully stimulates insulin secretion. Various therapeutic interventions use the hormonal ...

  4. PACTAID App In Adults With Type 1 Diabetes To Help Manage Exercise - Mayo Clinic

    * T1D diagnosis will be confirmed by C- Peptide (≤0.6 ng/ml) with a simultaneous fasting glucose concentration 80-225 mg/dL. * T1D using AID either tandem ...

  5. Publications - Ayse Tuba Kendi, M.D. - Mayo Clinic

    Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma. J Nucl Med. 2026 Jan 02; ...

  6. DAYBREAK: Phase 2 Study in Patients With Specific Gene Defects in the MC4R Pathway - Mayo Clinic

    Note: Glucagon-like peptide-1 (GLP-1) receptor agonists may be used up to the dose approved for the treatment of diabetes mellitus (e.g., liraglutide up to ...

  7. A Study of PDD in Type 2 Diabetes - Clinical Trials

    On at least one oral hypoglycemic agent, or glucagon-like peptide analogue or insulin, for at least 6 months. EF > 50% without diastolic dysfunction or EF ...

  8. Clinical trials - Oncology (Medical)

    A personalized neoantigen peptide vaccine containing up to 20 unique peptides will be manufactured for each qualifying patient based on the results. First ...

  9. Clinical trials - Oncology (Medical)

    A personalized neoantigen peptide vaccine containing up to 20 unique peptides will be manufactured for each qualifying patient based on the results. First ...

  10. Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients

    Known history of allergy to IL2, TNF, or other human proteins/peptides/antibodies or any other constituent of the product. Breast feeding female. Anti-tumor ...